Indivior PLC (INDV)

315.60
+2.00(+0.64%)
  • Volume:
    749,966
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    305.40 - 316.20

INDV Overview

Prev. Close
313.6
Day's Range
305.4-316.2
Revenue
690.51M
Open
306.4
52 wk Range
186.4-340
EPS
0.213
Volume
749,966
Market Cap
2.19B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,475,599
P/E Ratio
18.40
Beta
-0.278
1-Year Change
68.6%
Shares Outstanding
692,967,889
Next Earnings Date
03 Nov 2022
What is your sentiment on Indivior PLC?
or
Market is currently closed. Voting is open during market hours.

Indivior PLC News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Indivior PLC Analysis

Indivior PLC Company Profile

Indivior PLC Company Profile

Employees
885

Indivior PLC is a pharmaceutical company. The Company develops medicines to treat addiction and serious mental illnesses. It focuses on building a portfolio of opioid dependence treatments. It has a pipeline of product candidates designed to address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Its product pipeline focuses on development and discovery of non-opioid treatment strategies for opioid use disorder (OUD), as well as therapies to address the needs of people suffering from alcohol, stimulant, and cannabis use disorders. Its SUBLOCADE, SUBUTEX and SUBOXONE are used for the treatment of opioid use disorder (OUD). Its PERSERIS is used for the treatment of Schizophrenia. Its pipeline products include AEF0117, INDV-2000, INDV-1000, RBP-6000, RBP-7000, Buprenorphine/ Naloxone Sublingual Film, Buprenorphine/ Naloxone Sublingual Tablet, and Buprenorphine Sublingual Tablet. Its portfolio of products is available in over 40 countries.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuySellStrong Buy
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Buy
  • What a poor business. Extrodinary debt. No cash.
    1
    • totally agree. this is the crazy stock.
      0
  • potential 3 bln fines in US. company is broke.
    0
    • company tried settlement but rejected.the previous parent company has already set aside 400 million.
      0
  • any ideas
    1
    • where this will stop
      1